Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance

Purpose: Antimicrobial, cytotoxicity and clinical performance of a new soft contact lens multi-purpose solution (COMPLETE® RevitaLens) based on polyquaternium-1 and alexidine dihydrochloride (NuMPS) was evaluated. Methods: Antimicrobial efficacy was assessed according to ISO 14729 for both biocidal...

Full description

Bibliographic Details
Main Authors: Simon Kilvington, Ling Huang, Eugenia Kao, Charles H. Powell
Format: Article
Language:English
Published: Elsevier 2010-07-01
Series:Journal of Optometry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1888429610700194
id doaj-b76574fa84c149fdb7cd19dba1e3b22d
record_format Article
spelling doaj-b76574fa84c149fdb7cd19dba1e3b22d2020-11-25T01:49:01ZengElsevierJournal of Optometry1888-42962010-07-013313414210.1016/S1888-4296(10)70019-4Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performanceSimon KilvingtonLing HuangEugenia KaoCharles H. PowellPurpose: Antimicrobial, cytotoxicity and clinical performance of a new soft contact lens multi-purpose solution (COMPLETE® RevitaLens) based on polyquaternium-1 and alexidine dihydrochloride (NuMPS) was evaluated. Methods: Antimicrobial efficacy was assessed according to ISO 14729 for both biocidal and regimen performance against bacteria and fungi. Acanthamoeba efficacy was tested along with ability to retain antimicrobial activity on partial evaporation. In vitro cytotoxicity of NuMPS and OPTI-FREE® RepleniSH® MPS (MPS-3) was assessed based on ISO 10993-5 and United States Pharmacopeia (USP) methods. In addition, a 3 month, double-masked, parallel group clinical trial comparing safety and acceptability with respect to MPS-3 was conducted with 4 silicone hydrogel (SiHy) and FDA Group IV lens types. Results: NuMPS showed broad antimicrobial efficacy, including Acanthamoeba, giving a 3–4 log10 reduction in viability after 6 hours contact time. NuMPS also passed ISO 14729 regimens with SiHy and etafilcon lenses for bacteria, fungi and also Acanthamoeba. The cytotoxicity of NuMPS was equivalent or better compared to MPS-3. In the clinical trial, there was no statistically significant between-group difference in corneal staining (p > 0.05). Patients using MPS-3 had more adverse events than patients using NuMPS: 11.8 % (11/93) versus 2.8 % (5/177), respectively, (p < 0.05). There were no differences noted in cleanliness or wearing comfort (p > 0.05). Conclusion: Taken together, the results of these studies indicate that the NuMPS is a novel and effective soft contact lens care solution.http://www.sciencedirect.com/science/article/pii/S1888429610700194Contact lensMulti-purpose solutionDisinfectionCytotoxicityCorneal stainingAcanthamoeba
collection DOAJ
language English
format Article
sources DOAJ
author Simon Kilvington
Ling Huang
Eugenia Kao
Charles H. Powell
spellingShingle Simon Kilvington
Ling Huang
Eugenia Kao
Charles H. Powell
Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance
Journal of Optometry
Contact lens
Multi-purpose solution
Disinfection
Cytotoxicity
Corneal staining
Acanthamoeba
author_facet Simon Kilvington
Ling Huang
Eugenia Kao
Charles H. Powell
author_sort Simon Kilvington
title Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance
title_short Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance
title_full Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance
title_fullStr Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance
title_full_unstemmed Development of a new contact lens multipurpose solution: Comparative analysis of microbiological, biological and clinical performance
title_sort development of a new contact lens multipurpose solution: comparative analysis of microbiological, biological and clinical performance
publisher Elsevier
series Journal of Optometry
issn 1888-4296
publishDate 2010-07-01
description Purpose: Antimicrobial, cytotoxicity and clinical performance of a new soft contact lens multi-purpose solution (COMPLETE® RevitaLens) based on polyquaternium-1 and alexidine dihydrochloride (NuMPS) was evaluated. Methods: Antimicrobial efficacy was assessed according to ISO 14729 for both biocidal and regimen performance against bacteria and fungi. Acanthamoeba efficacy was tested along with ability to retain antimicrobial activity on partial evaporation. In vitro cytotoxicity of NuMPS and OPTI-FREE® RepleniSH® MPS (MPS-3) was assessed based on ISO 10993-5 and United States Pharmacopeia (USP) methods. In addition, a 3 month, double-masked, parallel group clinical trial comparing safety and acceptability with respect to MPS-3 was conducted with 4 silicone hydrogel (SiHy) and FDA Group IV lens types. Results: NuMPS showed broad antimicrobial efficacy, including Acanthamoeba, giving a 3–4 log10 reduction in viability after 6 hours contact time. NuMPS also passed ISO 14729 regimens with SiHy and etafilcon lenses for bacteria, fungi and also Acanthamoeba. The cytotoxicity of NuMPS was equivalent or better compared to MPS-3. In the clinical trial, there was no statistically significant between-group difference in corneal staining (p > 0.05). Patients using MPS-3 had more adverse events than patients using NuMPS: 11.8 % (11/93) versus 2.8 % (5/177), respectively, (p < 0.05). There were no differences noted in cleanliness or wearing comfort (p > 0.05). Conclusion: Taken together, the results of these studies indicate that the NuMPS is a novel and effective soft contact lens care solution.
topic Contact lens
Multi-purpose solution
Disinfection
Cytotoxicity
Corneal staining
Acanthamoeba
url http://www.sciencedirect.com/science/article/pii/S1888429610700194
work_keys_str_mv AT simonkilvington developmentofanewcontactlensmultipurposesolutioncomparativeanalysisofmicrobiologicalbiologicalandclinicalperformance
AT linghuang developmentofanewcontactlensmultipurposesolutioncomparativeanalysisofmicrobiologicalbiologicalandclinicalperformance
AT eugeniakao developmentofanewcontactlensmultipurposesolutioncomparativeanalysisofmicrobiologicalbiologicalandclinicalperformance
AT charleshpowell developmentofanewcontactlensmultipurposesolutioncomparativeanalysisofmicrobiologicalbiologicalandclinicalperformance
_version_ 1725009368113479680